Chemoinformaics analysis of N-(1-Carboxy-2-Methyl-Butyryl)-Lachnanthopyridone
Molecular Weight | 403.434 | nRot | 5 |
Heavy Atom Molecular Weight | 382.266 | nRig | 25 |
Exact Molecular Weight | 403.142 | nRing | 4 |
Solubility: LogS | -4.637 | nHRing | 1 |
Solubility: LogP | 3.95 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
nHA | 5 | APOL | 59.1927 |
nHD | 2 | BPOL | 25.3813 |
QED | 0.657 |
Synth | 3.531 |
Natural Product Likeliness | 0.307 |
NR-PPAR-gamma | 0.976 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.947 |
MDCK | 0.0000215 |
BBB | 0.056 |
PPB | 0.987238 |
VDSS | 0.198 |
FU | 0.00618656 |
CYP1A2-inh | 0.315 |
CYP1A2-sub | 0.114 |
CYP2c19-inh | 0.261 |
CYP2c19-sub | 0.125 |
CYP2c9-inh | 0.745 |
CYP2c9-sub | 0.861 |
CYP2d6-inh | 0.047 |
CYP2d6-sub | 0.127 |
CYP3a4-inh | 0.179 |
CYP3a4-sub | 0.271 |
CL | 2.767 |
T12 | 0.278 |
hERG | 0.025 |
Ames | 0.011 |
ROA | 0.374 |
SkinSen | 0.154 |
Carcinogencity | 0.164 |
EI | 0.016 |
Respiratory | 0.062 |
NR-Aromatase | 0.3 |
Antiviral | Yes |
Prediction | 0.628815 |